Mindray Medical Beats Estimates with Strong Q2 Report

Mindray Medical, the Shenzhen maker of medical devices, reported Q2 revenues climbed 23% to $267.8 million, handily beating expectations of $258.7 million. Per Share earnings were $.50, well ahead of the $.45 predicted by analysts. Because the report was a pleasant surprise, Mindray’s stock price rose almost 12% in today’s trading, moving up $3.61 to $34.96. More details.... Stock Symbol: (NYSE: MR) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});